Background Sepsis is a life‐threatening condition often manifested as marked inflammation and severe coagulopathy. Toll‐like receptors (TLRs) play a pivotal role in inflammation, organ dysfunction and mortality in animal sepsis. Objectives To investigate the role of TLR signaling in mediating sepsis‐induced coagulopathy (SIC) in a mouse model. Methods Polymicrobial sepsis was created by cecal ligation and puncture (CLP) or fecal slurry peritoneal injection. To quantify global clotting function, two viscoelastic assays were performed with rotational thromboelastometry, and the results were presented as maximum clot firmness (MCF): (a) EXTEM to test tissue factor (TF)‐initiated clot formation; and (b) FIBTEM to test EXTEM in the presence of a platelet inhibitor, cytochalasin D. Plasma coagulation factors were quantified with ELISA. TF gene expression and protein expression were determined with real‐time quantitative reverse transcription PCR and flow cytometry, respectively. Results Between 4 and 24 hours after CLP surgery, wild‐type mice showed significant MCF reduction in both EXTEM and FIBTEM tests. This was accompanied by marked thrombocytopenia and a significant increase in the levels of plasminogen activator inhibitor‐1, plasma TF, and D‐dimer. In comparison, TLR2−/− and TLR7−/− CLP mice showed preserved MCF and platelet counts, and near‐normal plasma TF levels. Bone marrow–derived macrophages treated with a TLR2 agonist Pam3cys‐Ser‐(Lys)4 (Pam3cys) or a TLR7 agonist (R837) showed marked increases in TF gene expression and protein expression. MicroRNA‐146a, a newly identified proinflammatory mediator that is upregulated during sepsis, induced TF production via a TLR7‐dependent mechanism. Conclusions Murine sepsis leads to an increased procoagulant response, thrombocytopenia, and global coagulopathy. TLR2 and TLR7 play an important role in procoagulant production and in SIC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.